Hennessy Advisors Inc. Boosts Position in DaVita Inc. (NYSE:DVA)

Hennessy Advisors Inc. grew its position in shares of DaVita Inc. (NYSE:DVA) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 73,300 shares of the company’s stock after purchasing an additional 4,700 shares during the quarter. Hennessy Advisors Inc. owned approximately 0.09% of DaVita worth $10,962,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC purchased a new position in DaVita during the 3rd quarter worth $25,000. Blue Trust Inc. lifted its position in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after purchasing an additional 119 shares during the period. Quarry LP purchased a new stake in DaVita in the 3rd quarter valued at approximately $60,000. Versant Capital Management Inc increased its position in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Point72 Hong Kong Ltd purchased a new position in shares of DaVita during the 2nd quarter worth approximately $68,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on DVA shares. Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Barclays lifted their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, DaVita currently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Stock Up 1.5 %

DVA stock opened at $164.83 on Friday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The company’s 50 day simple moving average is $156.78 and its 200-day simple moving average is $152.52. DaVita Inc. has a 12 month low of $103.40 and a 12 month high of $169.51. The firm has a market capitalization of $13.52 billion, a PE ratio of 17.78, a P/E/G ratio of 0.75 and a beta of 0.92.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the company posted $2.85 EPS. DaVita’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities analysts expect that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.